Patent Applications published on Oct 5, 2023 - page 4

#901
US20230310348A1
Human necessities

USE OF ALVERINE OR ITS DERIVATIVES FOR THE TREATMENT OF MITOCHONDRIAL DISEASES OR DYSFUNCTION ASSOCIATED WITH MITOCHONDRIAL COMPLEX I DEFICIENCIES

#902 ✅ Patent 12,303,472 granted on 2025-05-20
US20230310349A1
Human necessities

Pharmaceutical device for use in intranasal administration

#903
US20230310350A1
Human necessities

ANTIFUNGAL PROPHYLAXIS FOR CORNEA

#904
US20230310351A1
Human necessities

REGIMEN FOR REPEATED TOPICAL APPLICATION OF CAPSAICIN PATCH

#905
US20230310352A1
Human necessities

NOVEL COMPOSITIONS AND METHODS FOR THE TREATMENT OF LUNG FIBROSIS

#906
US20230310353A1
Human necessities

3-HYDROXYBUTYRATE ALONE OR IN COMBINATION FOR USE IN THE TREATMENT OF CRITICAL CARE TREATMENT

#907
US20230310354A1
Human necessities

USE OF CYP26-RESISTANT RAR ALPHA SELECTIVE AGONISTS IN THE TREATMENT OF CANCER

#908
US20230310355A1
Human necessities

SIRTUIN ACTIVATOR, AND METHOD FOR ACTIVATING SIRTUIN

#909
US20230310356A1
Human necessities

COMPOSITION FOR PREVENTING, AMELIORATING, OR TREATING BRAIN DAMAGE AND MILD COGNITIVE IMPAIRMENT COMPRISING GLUTAMINE AS EFFECTIVE COMPONENT

#910
US20230310357A1
Human necessities

ANALGESIC AGENT

#911
US20230310358A1
Human necessities

Compositions And Methods For Treating Autism

#912
US20230310359A1
Human necessities

Anti-Oncogenic Phytochemicals and Methods and Uses for Treating Cancer

#913
US20230310360A1
Human necessities

MCT FORMULATIONS FOR IMPROVING COGNITIVE FUNCTIONS

#914 ✅ Patent 11,969,404 granted on 2024-04-30
US20230310362A1
Human necessities

Methods of providing solriamfetol therapy to subjects with impaired renal function

#915
US20230310363A1
Human necessities

USE OF LEOLIGIN IN THE PREVENTION OF TISSUE DAMAGE

#916
US20230310364A1
Human necessities

COMPOSITIONS AND METHODS FOR THE TREATMENT OF OBSTRUCTIVE SLEEP APNOEA (OSA)

#917 ✅ Patent 12,059,401 granted on 2024-08-13
US20230310365A1
Human necessities

Slow release cannabinoids and products thereof

#918
US20230310367A1
Human necessities

COMPOSITION FOR ENHANCING NAMPT GENE EXPRESSION

#919
US20230310368A1
Human necessities

MDMA ENANTIOMERS

#920
US20230310369A1
Human necessities

METHOD AND COMPOSITION FOR INHIBITING VIRUS INFECTION

#921
US20230310371A1
Human necessities

AGENT FOR REDUCING AMOUNT OF AMYLOID B PROTEIN

#922
US20230310372A1
Human necessities

CO-ADMINISTRATION OF ATORVASTATIN AND ETHYL EICOSAPENTAENOIC ACID OR A DERIVATIVE THEREOF

#923
US20230310373A1
Human necessities

METHODS FOR TREATING PULMONARY EMPHYSEMA USING SUBSTITUTED 2-AZA-BICYCLO[2.2.1]HEPTANE-3-CARBOXYLIC ACID (BENZYL-CYANO-METHYL)-AMIDES INHIBITORS OF CATHEPSIN C

#924
US20230310374A1
Human necessities

COMPOSITIONS AND METHODS FOR TREATING HEADACHE OR FACIAL PAIN

#925
US20230310376A1
Human necessities

PROPHYLACTIC AND/OR THERAPEUTIC AGENT FOR IDIOPATHIC PULMONARY FIBROSIS

#926
US20230310377A1
Human necessities

METHODS OF TREATING LYSOSOMAL STORAGE DISEASES AND METHODS RELATED THERETO

#927
US20230310378A1
Human necessities

CO-THERAPIES INCLUDING A METASTASIS INHIBITOR

#928 ✅ Patent 11,844,780 granted on 2023-12-19
US20230310379A1
Human necessities

Chlorinated tetralin compounds and pharmaceutical compositions

#929
US20230310380A1
Human necessities

METHODS, DEVICES, AND SYSTEMS FOR TREATING LENS PROTEIN AGGREGATION DISEASES

#930
US20230310381A1
Human necessities

BENDAMUSTINE PHARMACEUTICAL COMPOSITIONS

#931
US20230310382A1
Human necessities

METHODS AND FORMULATIONS FOR TREATMENT OF SPINOBULBAR MUSCULAR ATROPHY

#932 ✅ Patent 12,128,031 granted on 2024-10-29
US20230310383A1
Human necessities

Method of improving psychosocial health

#933 ✅ Patent 11,844,784 granted on 2023-12-19
US20230310384A1
Human necessities

Stable pharmaceutical compositions of bendamustine

#934
US20230310385A1
Human necessities

TREATMENT OF ER-NEGATIVE BREAST CANCER WITH AN PDGF-CC INHIBITOR AND AN ANTI-ESTROGEN

#935
US20230310386A1
Human necessities

INJECTABLE PHARMACEUTICAL COMPOSITIONS AND USES THEREOF

#936 ✅ Patent 11,918,559 granted on 2024-03-05
US20230310387A1
Human necessities

Reduced dose metaxalone formulations

#937
US20230310388A1
Human necessities

Methods and Compositions for Treating Fungal Infections

#938
US20230310390A1
Human necessities

INHIBITORS OF SHORT-CHAIN DEHYDROGENASE ACTIVITY FOR TREATING NEURODEGENERATION

#939
US20230310391A1
Human necessities

COMBINATION OF AN ANTIMUSCARINIC OR AN ANTICHOLINERGIC AGENT AND LIPOIC ACID AND USES THEREOF

#940
US20230310392A1
Human necessities

COMPOSITIONS AND METHODS FOR THE TREATMENT OF EYE CONDITIONS

#941
US20230310393A1
Human necessities

SORAFENIB PHARMACEUTICAL COMPOSITION WITH HIGH BIOAVAILABILITY AND USE THEREOF

#942
US20230310394A1
Human necessities

SORAFENIB, REGORAFENIB AND NOVEL USE OF ANALOGUE OR DERIVATIVE THEREOF

#943
US20230310395A1
Human necessities

TOPICAL ROFLUMILAST COMPOSITIONS AND USES THEREOF

#944 ✅ Patent 11,819,496 granted on 2023-11-21
US20230310397A1
Human necessities

Topical roflumilast formulation having improved delivery and plasma half-life

#945 ✅ Patent 12,036,211 granted on 2024-07-16
US20230310398A1
Human necessities

Nicorandil derivatives

#946
US20230310399A1
Human necessities

COMBINATORIAL THERAPEUTIC SYSTEMS AND METHODS THAT INCLUDE SYSTEMIC, CENTRALLY AND PERIPHERALLY ACTING ANALGESICS

#947
US20230310400A9
Human necessities

SYNTHESIS OF SMALL MOLECULE HISTONE DEACETYLASE 6 DEGRADERS, COMPOUNDS FORMED THEREBY, AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM

#948
US20230310401A1
Human necessities

Pharmaceutical Composition Containing Dabigatran Etexilate And Preparation Method Thereof

#949
US20230310402A1
Human necessities

CORNEAL ENDOTHELIUM ECM THERAPEUTIC MEDICAMENTS

#950
US20230310404A1
Human necessities

COMPOSITIONS AND METHODS FOR REDUCING LAMINITIS OF AN ANIMAL HOOF

#951
US20230310405A1
Human necessities

METHODS FOR TREATING HYPERCHOLESTEROLEMIA

#952
US20230310406A1
Human necessities

TREATMENT OF NEUROLOGICAL DISORDERS

#953 ✅ Patent 12,246,011 granted on 2025-03-11
US20230310407A1
Human necessities

Radiation mitigator and method of use thereof

#954
US20230310408A1
Human necessities

TLR7 INHIBITOR IN COMBINATION WITH PREDNISOLONE OR HYDROXYCHLOROQUINE FOR TREATING CUTANEOUS LUPUS ERYTHEMATOSUS

#955
US20230310409A1
Human necessities

TREATING RHEUMATOID ARTHRITIS

#956
US20230310411A1
Human necessities

METHODS OF TREATMENT FOR A KIDNEY DISEASE

#957
US20230310412A1
Human necessities

USE OF CASPASE INHIBITOR FOR ALLEVIATING OR TREATING OSTEOARTHRITIS

#958
US20230310413A1
Human necessities

PHARMACEUTICAL FORMULATIONS COMPRISING A MALT1 INHIBITOR AND A MIXTURE OF POLYETHYLENE GLYCOL WITH A FATTY ACID

#959
US20230310414A1
Human necessities

METHODS AND COMPOSITIONS FOR TREATING VIRAL INFECTIONS WITH DOUBLE AND TRIPLE COMBINATIONS OF ANTIVIRAL AND IMMUNE MODULATING COMPOUNDS

#960
US20230310416A1
Human necessities

SUSPENSION OF TRIAZOLE ANTIFUNGAL DRUG FOR ATOMIZER

#961
US20230310417A1
Human necessities

INJECTABLE ARIPIPRAZOLE FORMULATION

#962
US20230310418A1
Human necessities

COMPOSITIONS AND METHODS FOR TREATING CANCER OR PREVENTING, INHIBITING OR REDUCING RISK OF METASTASIS OF A CANCER

#963
US20230310419A1
Human necessities

COMPOUNDS AND METHODS FOR TREATING CANCER

#964
US20230310420A1
Human necessities

METHODS AND COMPOSITIONS FOR HYPOTENSIVE RESUSCITATION

#965
US20230310421A1
Human necessities

MOLECULES FOR USE IN THE TREATMENT OF VIRAL INFECTIONS

#966
US20230310422A1
Human necessities

STABLE PHARMACEUTICAL COMPOSITION FOR ORAL ADMINISTRATION

#967
US20230310423A1
Human necessities

CHECKPOINT KINASE 1 (CHK1) INHIBITORS AND USES THEREOF

#968
US20230310424A1
Human necessities

METHODS AND MATERIALS FOR INCREASING NICOTINAMIDE PHOSPHORIBOSYL TRANSFERASE ACTIVITY

#969
US20230310426A1
Human necessities

COMBINATION OF LURBINECTEDIN AND IMMUNE CHECKPOINT INHIBITOR

#970
US20230310427A1
Human necessities

NEW THERAPEUTIC USE OF RILPIVIRINE

#971
US20230310428A1
Human necessities

EGFR INHIBITOR AND PREPARATION METHOD AND USE THEREOF

#972
US20230310429A1
Human necessities

FORMULATIONS FOR REDUCING HAIR LOSS AND/OR INCREASING HAIR REGROWTH

#973
US20230310430A1
Human necessities

PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING GRAFT VERSUS HOST DISEASE COMPRISING THIAMINE DERIVATIVES

#974
US20230310431A1
Human necessities

COMPOSITION FOR PREVENTING OR TREATING LIVER FIBROSIS, CONTAINING TRIAZOLE DERIVATIVE AS ACTIVE INGREDIENT

#975
US20230310432A1
Human necessities

CONTROL AND MODULATION OF THE FUNCTION OF GENE-MODIFIED CHIMERIC ANTIGEN RECEPTOR T CELLS WITH DASATINIB AND OTHER TYROSINE KINASE INHIBITORS

#976
US20230310433A1
Human necessities

COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOF FOR THE TREATMENT OF INFLAMMATORY DISORDERS

#977
US20230310434A1
Human necessities

METHODS OF REDUCING THE LIKELIHOOD OF CARCINOID HEART DISEASE IN PATIENTS WITH NEUROENDOCRINE TUMORS

#978
US20230310435A1
Human necessities

HOST DEFENSE PROTEIN (HDP) MIMETICS FOR PROPHYLAXIS AND/OR TREATMENT OF INFLAMMATORY DISEASES OF THE GASTROINTESTINAL TRACT

#979
US20230310436A1
Human necessities

COMBINATION THERAPY FOR CANCERS WITH KRAS MUTATION

#980 ✅ Patent 12,295,955 granted on 2025-05-13
US20230310437A1
Human necessities

TTP phosphorylation for the identification of personalized medicines

#981
US20230310438A1
Human necessities

TLR7/8 AGONISTS TO ENHANCE IMMUNE RESPONSES IN OPIOID USING INDIVIDUALS

#982
US20230310439A1
Human necessities

VIRAL PROPHYLAXIS TREATMENT METHODS AND PRE-EXPOSURE PROPHYLAXIS KITS

#983
US20230310440A1
Human necessities

RESPIRATORY STIMULANT NASAL FORMULATIONS

#984
US20230310441A1
Human necessities

TREATMENT FOR SCHIZOPHRENIA

#985
US20230310442A1
Human necessities

POLY HYDROXY OLIGOMER COATED DOLUTEGRAVIR AQUASOMES AND METHOD THEREOF

#986
US20230310443A1
Human necessities

Emulsion, Injection Agent, and Emulsion Preparation Method

#987
US20230310444A1
Human necessities

COMPOSITIONS AND METHODS FOR TREATING DISEASES AND DISORDERS

#988
US20230310445A1
Human necessities

LOX ENZYME INHIBITING METHODS AND COMPOSITIONS

#989
US20230310446A1
Human necessities

RHO KINASE INHIBITION FOR TREATMENT OF PROLIFERATIVE VITREORETINOPATHY AND CONDITIONS ASSOCIATED WITH EPITHELIAL TO MESENCHYMAL TRANSITION

#990
US20230310447A1
Human necessities

METHODS OF TREATING AGE-RELATED COGNITIVE DECLINE

#991 ✅ Patent 11,951,111 granted on 2024-04-09
US20230310451A1
Human necessities

Immediate release multilayer tablet

#992
US20230310452A1
Human necessities

BROMODOMAIN AND EXTRA TERMINAL DOMAIN (BET) INHIBITOR COMPOSITIONS AND METHODS THEREOF FOR USE AS ANTI-AGING AGENTS

#993
US20230310453A1
Human necessities

METHODS FOR EXTRACTING NEUTROPHIL SERINE PROTEASES AND TREATING DIPEPTIDYL PEPTIDASE 1-MEDIATED CONDITIONS

#994
US20230310454A1
Human necessities

RIP1 INHIBITORY COMPOUNDS AND METHODS FOR MAKING AND USING THE SAME

#995
US20230310455A1
Human necessities

COMBINATION THERAPIES FOR TREATMENT OF HER2 CANCER

#996
US20230310458A1
Human necessities

USES OF OXYGENATED CHOLESTEROL SULFATES (OCS)

#997
US20230310459A1
Human necessities

NEUROACTIVE STEROIDS AND THEIR METHODS OF USE

#998
US20230310460A1
Human necessities

Low Dose Topical Composition Comprising Triamcinolone Acetonide or Salt Thereof

#999
US20230310461A1
Human necessities

Compositions and Methods for Treatment of Prediabetes

#1000
US20230310462A1
Human necessities

COMBINATION DRUG FOR THE CONTROL AND MANAGEMENT OF TYPE 2 DIABETES MELLITUS

#1001
US20230310463A1
Human necessities

USE OF CANNABIDIOL IN THE TREATMENT OF SEIZURES ASSOCIATED WITH RARE EPILEPSY SYNDROMES RELATED TO GENETIC ABNORMALITIES

#1002
US20230310464A1
Human necessities

USE OF CANNABIDIOL IN THE TREATMENT OF SEIZURES ASSOCIATED WITH RARE EPILEPSY SYNDROMES RELATED TO BRAIN INJURY

#1003
US20230310465A1
Human necessities

NANO LIPID CARRIER SYSTEM FOR IMPROVING PERMEATION OF ACTIVE INGREDIENTS

#1004
US20230310467A1
Human necessities

PHARMACEUTICAL COMBINATION THERAPY AND PREVENTION WITH APROTININ + REMDESIVIR OF SARS-CoV-2 AND/OR DISEASE ASSOCIATED WITH THIS INFECTION, INCLUDI COVID-19

#1005
US20230310468A1
Human necessities

Parenteral pharmaceutical composition comprising cyclophosphamide and a mixture of liquids

#1006
US20230310469A1
Human necessities

METHODS OF TREATING SYMPTOMS OF CORONAVIRUS INFECTION WITH TOLL-LIKE-RECEPTOR AGONISTS

#1007
US20230310470A1
Human necessities

INTELLIGENT DELIVERY OF INGESTED AND ABSORBED MOLECULES

#1008
US20230310471A1
Human necessities

METHODS, DEVICES, AND SYSTEMS FOR TREATING LENS PROTEIN AGGREGATION DISEASES

#1009
US20230310472A1
Human necessities

Stable Topical Formulations of 1(R)-4-(5-(4-Methoxy-3-Propoxphenyl)Pyridin-3-YL)-1,2-OX-Aborolan-2-OL

#1010
US20230310473A1
Human necessities

METHOD FOR TREATING OBESITY AND/OR HYPERTENSION

#1011
US20230310474A1
Human necessities

CORONAVIRUS TREATMENT COMPOSITION AND METHOD

#1012
US20230310475A1
Human necessities

METHODS FOR TREATMENT OF POST-SURGERY LAXITY OF TENDONS AND TENDON REPAIR

#1013
US20230310477A1
Human necessities

PHARMACEUTICAL COMPOSITION COMPRISING ABELIOPHYLLUM DISTICHUM EXTRACT AS ACTIVE INGREDIENT FOR TREATING ANDROGEN RECEPTOR-RELATED DISEASE

#1014
US20230310478A1
Human necessities

METHODS AND COMPOSITIONS FOR THE TREATMENT OF PULMONARY HYPERTENSION AND CANCER

#1015
US20230310479A1
Human necessities

LOW DOSE ADJUVANT EPIGENETIC CANCER THERAPY

#1016
US20230310480A1
Human necessities

PHARMACEUTICAL COMBINATION THERAPY AND PREVENTION WITH APROTININ + MOLNUPIRAVIR OF SARS-CoV-2 AND/OR DISEASE ASSOCIATED WITH THIS INFECTION, INCLUDI COVID-19

#1017
US20230310481A1
Human necessities

BI- AND MONOCYCLIC NUCLEOSIDE ANALOGS FOR TREATMENT OF HEPATITIS E

#1018
US20230310483A1
Human necessities

MODULATORS OF HSD17B13 EXPRESSION

#1019 ✅ Patent 11,951,120 granted on 2024-04-09
US20230310484A1
Human necessities

Modification of gene transcription and translation efficiency by 5′UTR sequence variation

#1020
US20230310485A1
Human necessities

POLYNUCLEOTIDE AGENTS TARGETING ANGIOTENSINOGEN (AGT) AND METHODS OF USE THEREOF

#1021
US20230310486A1
Human necessities

CONJUGATED OLIGONUCLEOTIDE COMPOUNDS, METHODS OF MAKING AND USES THEREOF

#1022
US20230310488A1
Human necessities

COMPOSITIONS AND METHODS THAT ATTENUATE COGNITIVE AGING IN INDIVIDUALS WHO DO NOT HAVE DEMENTIA

#1023
US20230310490A1
Human necessities

THERAPY TO STIMULATE HIPPOCAMPAL NEURAL PROGENITORS AND ADULT NEUROGENESIS

#1024
US20230310492A1
Human necessities

SULPHATED XYLANS FOR TREATMENT OR PROPHYLAXIS OF RESPIRATORY DISEASES

#1025
US20230310493A1
Human necessities

REDUCTION OF ADVANCED GLYCATION ENDPRODUCTS FROM BODILY FLUIDS

#1026
US20230310496A1
Human necessities

COMPOSITIONS AND METHODS FOR PREVENTING AND/OR AMELIORATING ORGAN-SPECIFIC AUTOIMMUNE DISEASES

#1027
US20230310497A1
Human necessities

DISINFECTING, SKIN-TOLERABLE CARE AGENT FOR APPLICATION TO THE SKIN

#1028
US20230310499A1
Human necessities

PLASMA EXCHANGE REMOVAL OF SPD-L1

#1029
US20230310500A1
Human necessities

Use of Immune Killer Cell Against Circulating Tumor Cells in Solid Tumor Treatment

#1030
US20230310501A1
Human necessities

T CELLS EXPRESSING CHEMOKINE RECEPTORS FOR TREATING CANCER

#1031
US20230310502A1
Human necessities

TARGETED REPLACEMENT OF ENDOGENOUS T CELL RECEPTORS

#1032
US20230310504A1
Human necessities

PLATELET MEMBRANE COATED NANOPARTICLES AND USES THEREOF

#1033
US20230310505A1
Human necessities

COMPOSITION FOR PREVENTING HEARING LOSS CONTAINING MESENCHYMAL STEM CELLS OR EXOSOMES DERIVED THEREFROM AS ACTIVE INGREDIENT

#1034
US20230310506A1
Human necessities

METHOD FOR ACTIVATING EXPRESSION OF GAMMA-GLOBIN GENE, AND COMPOSITION

#1035
US20230310507A1
Human necessities

METHODS AND COMPOSITIONS FOR TREATING LUNG CONDITIONS

#1036
US20230310508A1
Human necessities

HEMATOPOIETIC STEM CELL ENGRAFTMENT WITH A COMBINATION OF AGENTS

#1037
US20230310509A1
Human necessities

Treatment of Alzheimer's Disease with Allogeneic Mesenchymal Stem Cells

#1038
US20230310510A1
Human necessities

FASL-ENGINEERED BIOMATERIALS WITH IMMUNOMODULATORY FUNCTION

#1039
US20230310511A1
Human necessities

TISSUE ENGINEERING OF LUNG

#1040
US20230310512A1
Human necessities

UMBILICAL CORD PRODUCTS

#1041
US20230310513A1
Human necessities

METHOD FOR FEEDING A FLATWORM AND FLATWORM EXTRACT FREE OF HUMAN-PATHOGENIC MICROORGANISMS

#1042
US20230310514A1
Human necessities

Dietary Method for Treating Arthritis

#1043
US20230310515A1
Human necessities

COMPOSITIONS AND METHODS FOR TREATING SKIN INFECTIONS AND OTHER DISEASES

#1044 ✅ Patent 12,036,250 granted on 2024-07-16
US20230310516A1
Human necessities

Microbiota restoration therapy (MRT) compositions and methods of manufacture

#1045
US20230310517A1
Human necessities

COMPOSITIONS COMPRISING BACTERIAL STRAINS

#1046
US20230310518A1
Human necessities

Compositions and Methods for Treating Infections of the Gastrointestinal Tract

#1047
US20230310519A1
Human necessities

USE OF ADLERCREUTZIA BACTERIA FOR THE TREATMENT OF INFLAMMATORY DISEASES

#1048
US20230310520A1
Human necessities

COMPOSITIONS AND METHODS FOR PROMOTING NITRIC OXIDE PRODUCTION THROUGH AN ORAL DELIVERY SYSTEM

#1049
US20230310521A1
Human necessities

COMBINATION COMPRISING BACILLUS AND AN ESSENTIAL OIL AND METHODS FOR MAKING AND USING

#1050
US20230310522A1
Human necessities

COMPOSITION WITH ANTIBACTERIAL AND RE-EPITHELIALIZING ACTION INCLUDING PROBIOTICS

#1051 ✅ Patent 12,005,091 granted on 2024-06-11
US20230310523A1
Human necessities

Use of lactic acid bacteria or fermentation product thereof for maintaining or improving gastrointestinal condition

#1052
US20230310524A1
Human necessities

LACTOBACILLUS PLANTARUM MICROORGANISMS HAVING ANTI-CANCER ACTIVITY, COMPOSITION INCLUDING SAME, AND METHOD FOR PREVENTING OR TREATING CANCER USING SAME

#1053
US20230310525A1
Human necessities

BACTERIOPHAGE VARIANTS HAVING EXTENDED HOST-RANGE, METHODS FOR PREPARATION AND USES THEREOF IN TRANSDUCING NUCLEIC ACIDS INTO HOSTS OF INTEREST

#1054 ✅ Patent 11,986,503 granted on 2024-05-21
US20230310526A1
Human necessities

Replication competent attenuated vaccinia viruses with deletion of thymidine kinase with and without the expression of human Flt3L or GM-CSF for cancer immunotherapy

#1055
US20230310527A1
Human necessities

CHINESE HERBAL MEDICINE COMPOSITION FOR IMPROVING HEARING IMPAIRMENT, AND PREPARATION METHOD AND APPLICATION THEREOF

#1056
US20230310528A1
Human necessities

DEEP EUTECTIC SOLVENT INCLUDING ONE OR MORE ACTIVE PHARMACEUTICAL INGREDIENTS DERIVED FROM MUSHROOMS

#1057 ✅ Patent 11,826,392 granted on 2023-11-28
US20230310529A1
Human necessities

Purification method of fungal cell wall composition

#1058
US20230310530A1
Human necessities

Composition Based on Natural Ingredients and Use of the Composition for Improving Mental Health

#1059
US20230310531A1
Human necessities

TRIPTERYGIUM WILFORDII COMPOSITION FOR INHIBITING DRUG-RESISTANT CANCER, AND PREPARATION METHOD AND USE THEREOF

#1060
US20230310532A1
Human necessities

FOOD EXTRACTS, METHODS OF EXTRACTION AND COMPOSITIONS THEREOF

#1061
US20230310533A1
Human necessities

ACTIVE PHARMACEUTICAL INGREDIENT

#1062
US20230310534A1
Human necessities

QUENCHERS THAT SLOW, DECREASE, OR INHIBIT THE FORMATION OF CHEMIEXCITATION-INDUCED CYCLOBUTANE PYRIMIDINE DIMERS

#1063
US20230310535A1
Human necessities

ORAL RINSE FOR MANAGEMENT OF POST-ORAL SURGICAL RECOVERY AND MAINTENANCE OF ORAL HEALTH

#1064
US20230310536A1
Human necessities

WATER SOLUBLE CURCUMINOIDS COMPOSITION FOR TREATING MOUTH AND THROAT CONDITIONS

#1065
US20230310537A1
Human necessities

TREATMENT OF VASCULAR EHLERS-DANLOS SYNDROME AND RELATED SYNDROMES

#1066
US20230310538A1
Human necessities

TISSUE REPAIR AND WOUND HEALING COMPOSITION AND METHOD USING LOW MOLECULAR WEIGHT HYDROLYZED COLLAGEN

#1067
US20230310539A1
Human necessities

TREATMENT OF DISEASE WITH EPOR ANTAGONIST

#1068
US20230310540A1
Human necessities

PEPTIDE COMPOSITIONS AND METHODS OF USE THEREOF

#1069 ✅ Patent 12,161,689 granted on 2024-12-10
US20230310541A1
Human necessities

Anti-infective formulations

#1070
US20230310542A1
Human necessities

EPIGENETIC MODIFIERS TO TREAT RETINAL DEGENERATIONS

#1071
US20230310543A1
Human necessities

NOVEL COMPOSITION FOR PREVENTION OR TREATMENT OF STAPHYLOCOCCUS AUREUS INFECTIOUS DISEASE

#1072
US20230310544A1
Human necessities

ANTI-RNA VIRAL PHARMACEUTICAL COMBINATION THERAPY WITH APROTININ + anti-RNA DRUG

#1073
US20230310545A1
Human necessities

C3B BINDING POLYPEPTIDE

#1074
US20230310546A1
Human necessities

METHODS FOR INDUCING CELL DIVISION OF POSTMITOTIC CELLS

#1075 ✅ Patent 11,911,442 granted on 2024-02-27
US20230310547A1
Human necessities

Use of soluble pro(renin) receptor to treat metabolic disorders and related conditions

#1076
US20230310548A1
Human necessities

APPLICATION OF IFN-y IN PREPARING ANTI-TUMOR ADJUVANT DRUG

#1077
US20230310549A1
Human necessities

PREVENTING CYTOKINE RELEASE SYNDROME

#1078
US20230310551A1
Human necessities

INSULIN RECEPTOR PARTIAL AGONISTS

#1079
US20230310552A1
Human necessities

BIOMIMETIC WOUND HEALING DEVICES AND RELATED METHODS OF TREATING DIABETIC WOUNDS

#1080
US20230310553A1
Human necessities

WOUND HEALING AND TISSUE REPAIR COMPOSITION AND METHOD USING LOW MOLECULAR WEIGHT COLLAGEN AND BIOACTIVE GLASS

#1081
US20230310554A1
Human necessities

MEDICINE CONTAINING METHEMOGLOBIN ENDOPLASMIC RETICULUM AS ACTIVE INGREDIENT AND USE THEREOF

#1082
US20230310555A1
Human necessities

COMPOSITIONS FOR GENOME EDITING AND METHODS OF USE THEREOF

#1083
US20230310556A1
Human necessities

PREVENTION AND TREATMENT OF DISEASES USING PHYTASE

#1084
US20230310557A1
Human necessities

RECOMBINANT IMMUNOTOXIN COMPRISING A RIBOTOXIN OR RNASE

#1085
US20230310558A1
Human necessities

ALKALINE PHOSPHATASE AGENTS FOR TREATMENT OF RADIATION DISORDERS

#1086
US20230310559A1
Human necessities

Use of Amylase or Maltose to Treat or Prevent Neurodegeneration

#1087
US20230310560A1
Human necessities

FACTOR IX POLYPEPTIDE FORMULATIONS

#1088
US20230310561A1
Human necessities

IMMUNOGENIC COMPOSITION TARGETING PHOSPHORYLATED TAU PROTEIN

#1089 ✅ Patent 12,036,272 granted on 2024-07-16
US20230310562A1
Human necessities

Antigen presenting scaffolds for immune-cell manipulation

#1090
US20230310563A1
Human necessities

ANTIGEN-ENCODING CASSETTES

#1091
US20230310564A1
Human necessities

Attenuated Mycoplasma Bacteria

#1092 ✅ Patent 12,178,865 granted on 2024-12-31
US20230310566A1
Human necessities

CDKN2A companion diagnostic for bladder cancer interferon therapy

#1093
US20230310567A1
Human necessities

NEISSERIA MENINGITIDIS VACCINE

#1094
US20230310568A1
Human necessities

ENGINEERED ARENAVIRUS GLYCOPROTEIN COMPOSITIONS AND METHODS OF USE THEREOF

#1095
US20230310569A1
Human necessities

GENETICALLY-ADJUVANTED RNA VACCINES

#1096
US20230310570A1
Human necessities

COMPOSITIONS AND METHODS FOR VACCINATION OF JUVENILES AGAINSTRESPIRATORY SYNCYTIAL VIRUS INFECTION

#1097
US20230310571A1
Human necessities

HUMAN METAPNEUMOVIRUS VACCINES

#1098
US20230310573A1
Human necessities

Stabilized Vaccine Compositions

#1099
US20230310574A1
Human necessities

MULTIVALENT VACCINES AGAINST TURKEY ARTHRITIS REOVIRUS

#1100
US20230310575A1
Human necessities

Hemagglutinin Modifications for Improved Influenza Vaccine Production

#1101
US20230310576A1
Human necessities

BROAD SPECTRUM INFLUENZA VIRUS VACCINE

#1102 ✅ Patent 12,201,681 granted on 2025-01-21
US20230310577A1
Human necessities

Removal of agglomerates

#1103 ✅ Patent 12,076,391 granted on 2024-09-03
US20230310578A1
Human necessities

Method for adapting influenza viruses to Vero cells

#1104 ✅ Patent 12,303,560 granted on 2025-05-20
US20230310579A1
Human necessities

Recombinant bovine immunodeficiency virus-like particles comprising an influenza HA transmembrane domain and C-terminus

#1105
US20230310581A1
Human necessities

A LIVE ATTENUATED MEASLES VIRUS VECTORED VACCINE FOR SARS-COV-2

#1106
US20230310582A1
Human necessities

SARS-2 SPIKE PROTEIN DESIGNS, COMPOSITIONS AND METHODS FOR THEIR USE

#1107
US20230310583A1
Human necessities

RECOMBINANT NEWCASTLE DISEASE VIRUS EXPRESSING SARS-COV-2 SPIKE PROTEIN AND USES THEREOF

#1108
US20230310584A1
Human necessities

NUCLEIC ACIDS ENCODING A POLYPEPTIDE COMPRISING A MODIFIED FC REGION OF A HUMAN IGG1 AND AT LEAST ONE HETEROLOGOUS ANTIGEN

#1109
US20230310585A1
Human necessities

VACCINE FOR VIRAL PATHOGENS

#1110
US20230310587A1
Human necessities

NOVEL IMMUNOGENIC CORONAVIRUS PEPTIDES AND COMPOSITIONS THEREOF

#1111 ✅ Patent 12,280,106 granted on 2025-04-22
US20230310589A1
Human necessities

Modified Marek's disease virus, and vaccines made therefrom

#1112 ✅ Patent 12,005,116 granted on 2024-06-11
US20230310590A1
Human necessities

Hepatitis C virus immunogenic compositions and methods of use thereof

#1113
US20230310591A1
Human necessities

Vaccine Boost Methods and Compositions

#1114
US20230310593A1
Human necessities

TOLEROGENIC SYNTHETIC NANOCARRIERS FOR ALLERGY THERAPY

#1115
US20230310594A1
Human necessities

METHODS OF TREATING A LATENT HIV-1 INFECTION USING NON-CODING DEOXYRIBONUCLEIC ACIDS

#1116
US20230310595A1
Human necessities

USE OF RILUZOLE, RILUZOLE PRODRUGS OR RILUZOLE ANALOGS WITH IMMUNOTHERAPIES TO TREAT CANCERS

#1117
US20230310596A1
Human necessities

DRUG FOR TREATING TUMOR

#1118
US20230310597A1
Human necessities

Combination Of The Application Of Antibodies For Immunostimulation Together With Glucocorticoids

#1119
US20230310599A1
Human necessities

ANTIBODY THERAPY

#1120
US20230310600A1
Human necessities

ENGINEERED CELLS AND METHOD FOR ENGINEERING CELLS

#1121
US20230310601A1
Human necessities

CHIMERIC ANTIGEN RECEPTOR-MODIFIED IMMUNE CELLS EXPRESSING A SECRETABLE BISPECIFIC TRAP PROTEIN AND USES THEREOF

#1122
US20230310602A1
Human necessities

COMPOSITIONS AND METHODS FOR TREATMENT OF INFLAMMATORY DISORDERS

#1123
US20230310603A1
Human necessities

ANTI-CD133 SINGLE-CHAIN ANTIBODY AND USE THEREOF IN PREPARATION OF DRUG FOR TREATING TUMOR

#1124
US20230310604A1
Human necessities

BCMA CHIMERIC ANTIGEN RECEPTORS

#1125
US20230310605A1
Human necessities

METHODS FOR CULTURING CELLS EXPRESSING ROR1-BINDING PROTEIN

#1126
US20230310606A1
Human necessities

CHIMERIC MYD88 RECEPTORS FOR REDIRECTING IMMUNOSUPPRESSIVE SIGNALING AND RELATED COMPOSITIONS AND METHODS

#1127
US20230310607A1
Human necessities

METHODS OF SELECTING A PATIENT FOR TREATMENT OF A MAGE-A1 POSITIVE SOLID TUMOR, OF PREDICTING WHETHER A PATIENT BEING DIAGNOSED WITH MAGE-A1 POSITIVE SOLID TUMOR WILL BE RESPONSIVE TO TREATMENT OF THIS TUMOR AND OF TREATING A PATIENT BEING DIAGNOSED WITH SUCH A MAGE-A1 POSITIVE SOLID TUMOR AS WELL AS CORRESPONDING PHARMACEUTICAL COMPOSITIONS AND DIAGNOSTIC KITS

#1128
US20230310608A1
Human necessities

IMMUNOTHERAPY

#1129
US20230310609A1
Human necessities

INJECTABLE HYDROGELS AND METHODS OF CAPTURING CELLS USING THE SAME

#1130
US20230310610A1
Human necessities

Long-Lived Gadolinium Based Tumor Targeted Imaging and Therapy Agents

#1131
US20230310612A1
Human necessities

ANTI-VIRAL COMPOSITION AND METHOD FOR PREPARING THE SAME

#1132
US20230310613A1
Human necessities

CELL ENCAPSULATION DEVICES AND METHODS OF USING SAME

#1133
US20230310614A1
Human necessities

Medium for Tissue for Transplantation

#1134
US20230310615A1
Human necessities

OPHTHALMIC COMPOSITIONS

#1135
US20230310616A1
Human necessities

LIQUID PHARMACEUTICAL COMPOSITIONS OF POLYPEPTIDE CONJUGATES AND METHODS OF USES THEREOF

#1136
US20230310617A1
Human necessities

MICRORNA OLIGONUCLEOTIDE THERAPEUTICS FOR OVARIAN CANCER

#1137
US20230310618A1
Human necessities

CONJUGATE FOR TARGETING THERAPY

#1138
US20230310621A1
Human necessities

COMPLEXES FOR THE DELIVERY OF PROTEINACEOUS AGENTS

#1139
US20230310623A1
Human necessities

COMPOSITIONS AND METHODS FOR TARGETING TUMOR ASSOCIATED TRANSCRIPTION FACTORS

#1140
US20230310624A1
Human necessities

AFFIBODY-CYTOTOXIN CONJUGATE FOR ACTIVE TARGETED THERAPY OF TUMORS, NANOPARTICLE THEREOF, PREPARATION METHOD THEREOF AND APPLICATION THEREOF

#1141 ✅ Patent 12,239,715 granted on 2025-03-04
US20230310625A1
Human necessities

Peptide oligonucleotide conjugates

#1142
US20230310627A1
Human necessities

COMBINATION THERAPY WITH ANTI-TROP-2 ANTIBODIES AND PARP INHIBITORS

#1143
US20230310628A1
Human necessities

Multi-Targeted Multi-Valent Ligand Drug Particles for the Treatment and Prevention of Diseases and Conditions

#1144
US20230310629A1
Human necessities

BISPECIFIC ANTIBODY-DRUG CONJUGATES TARGETING EGFR AND MUC1 AND USES THEREOF

#1145
US20230310630A1
Human necessities

THERAPEUTIC USE OF COMBINATION COMPRISING TRIPLE AGONISTIC LONG-ACTING CONJUGATE OR TRIPLE AGONIST

#1146
US20230310631A1
Human necessities

THERAPEUTIC USE OF GLUCAGON DERIVATIVE OR CONJUGATE THEREOF FOR LIVER DISEASE

#1147
US20230310633A1
Human necessities

BINDING MODULATOR

#1148
US20230310634A1
Human necessities

ANTI-HUMAN VISTA ANTIBODIES AND USE THEREOF

#1149
US20230310636A1
Human necessities

COMBINATION THERAPIES FOR TREATMENT OF CANCER WITH THERAPEUTIC BINDING MOLECULES

#1150
US20230310637A1
Human necessities

Glycan-dependent Immunotherapeutic Molecules

#1151
US20230310640A1
Human necessities

PYRROLOBENZODIAZEPINE DERIVATIVE AND LIGAND-LINKER CONJUGATE THEREOF

#1152
US20230310641A1
Human necessities

Site-specific antibody conjugation and its use

#1153
US20230310643A1
Human necessities

EXTRACORPOREAL CLEARING TRAPS BASED ON INVERSE ELECTRON DEMAND DIELS-ALDER CYCLOADDITION FOR (PRE)-TARGETED THERAPY AND DIAGNOSTICS

#1154 ✅ Patent 11,911,485 granted on 2024-02-27
US20230310644A1
Human necessities

Ionizable lipid compounds, lipid nanoparticles comprising same and therapeutic uses thereof

#1155
US20230310645A1
Human necessities

NANOPARTICLE COMPOSITION FOR THE DELIVERY OF NUCLEIC ACID AGENTS

#1156
US20230310646A1
Human necessities

SALT RESPONSIVE NANOGELS AND NANOPARTICLES

#1157
US20230310647A1
Human necessities

TARGETING CARTILAGE EGFR PATHWAY FOR OSTEOARTHRITIS TREATMENT

#1158
US20230310650A1
Human necessities

Bacterial Vehicle for Engineering of Non-Phagocytic Immune Cells

#1159
US20230310651A1
Human necessities

METHODS FOR MODULATING RNA SPLICING

#1160
US20230310652A1
Human necessities

VLP FOR THE TREATMENT OF LEUKODYSTROPHIES

#1161
US20230310653A1
Human necessities

THERAPEUTIC AGENT FOR EGFR GENE MUTATION-POSITIVE LUNG CANCER COMPRISING REIC/Dkk-3 GENE

#1162
US20230310654A1
Human necessities

GENE THERAPIES FOR LYSOSOMAL DISORDERS

#1163
US20230310655A1
Human necessities

ISOLATED NUCLEIC ACID MOLECULE AND APPLICATION THEREOF

#1164
US20230310657A1
Human necessities

MODIFIED MGLUR6 PROMOTER AND METHODS OF USE

#1165 ✅ Patent 12,011,489 granted on 2024-06-18
US20230310658A1
Human necessities

Compositions and methods for treating inflammatory disease

#1166
US20230310659A1
Human necessities

ANKYRIN-RICH BTB/POZ DOMAIN-CONTAINING PROTEIN-2 (ABTB2) FOR SUPPRESSING PANCREATIC CANCER GROWTH

#1167
US20230310660A1
Human necessities

SHELF-STABLE INDOCYANINE GREEN SOLUTIONS AND METHODS OF MAKING THE SAME

#1168
US20230310661A1
Human necessities

OPHTHALMIC DYE

#1169
US20230310662A1
Human necessities

METHODS FOR DIAGNOSING AND MONITORING EOSINOPHILIC ESOPHAGITIS

#1170
US20230310663A1
Human necessities

METHOD OF SYNTHESIZING 18F RADIOLABELED BIOMOLECULAR AGENTS

#1171
US20230310665A1
Human necessities

METHOD FOR PRODUCING 225AC SOLUTION

#1172 ✅ Patent 11,964,029 granted on 2024-04-23
US20230310666A1
Human necessities

Radioactive conduit and method for in vivo treatment of tumors

#1173 ✅ Patent 12,048,772 granted on 2024-07-30
US20230310667A1
Human necessities

Pipette carousel with germicidal lamp

#1174
US20230310668A1
Human necessities

Mask Portable Sterilizing Device

#1175 ✅ Patent 12,194,165 granted on 2025-01-14
US20230310669A1
Human necessities

Mobile sterilization apparatus and method for using the same

#1176 ✅ Patent 12,274,801 granted on 2025-04-15
US20230310670A1
Human necessities

Spirometer sterilizing assembly

#1177
US20230310671A1
Human necessities

Elongated Germicidal Lighting Device

#1178
US20230310672A1
Human necessities

Apparatus and Method for Sanitizing an Area

#1179 ✅ Patent 12,329,866 granted on 2025-06-17
US20230310673A1
Human necessities

SELECTIVE SMART AIR-SURFACE STERILIZATION SYSTEM BASED ON OCCUPIED SITUATION AND EMPTY SITUATON

#1180
US20230310674A1
Human necessities

LIGHT IRRADIATION SYSTEM

#1181
US20230310675A1
Human necessities

Hygienic Interface for Electronic Devices

#1182
US20230310676A1
Human necessities

ULTRAVIOLET IRRADIATION DEVICE

#1183
US20230310677A1
Human necessities

STERILIZATION DEVICE AND METHOD BY COMBINING COLD PLASMA AND ULTRAVIOLET LIGHT

#1184 ✅ Patent 12,274,804 granted on 2025-04-15
US20230310678A1
Human necessities

Decontamination device and method using shearing of cleaning fluid by cavitation

#1185
US20230310679A1
Human necessities

Disinfection Device For Female Connectors

#1186
US20230310680A1
Human necessities

FLUID CONTAINMENT LAYER AND PAD CONTAINING FLUID CONTAINMENT LAYER

#1187 ✅ Patent 12,220,496 granted on 2025-02-11
US20230310681A1
Human necessities

Prefilled syringe and method of preparing a prefilled syringe

#1188
US20230310682A1
Human necessities

APPARATUS FOR DISINFECTING AT LEAST ONE ROOM, IN PARTICULAR A DWELLING ROOM FOR PERSONS, WITH AN ATOMISER

#1189
US20230310683A1
Human necessities

ROBOT

#1190
US20230310684A1
Human necessities

DEVICE FOR DISINFECTING AN INTERIOR SPACE

#1191
US20230310685A1
Human necessities

Sterilization Indicator Sensor with a Sterilant-Responsive Switch

#1192
US20230310686A1
Human necessities

MULTI-FUNCTIONAL POWDER IMCREE AND MANUFACTURING METHOD THEREFOR

#1193 ✅ Patent 12,251,502 granted on 2025-03-18
US20230310687A1
Human necessities

Ultraviolet light radiation disinfection fixture

#1194
US20230310688A1
Human necessities

SENSOR SYSTEMS AND METHODS

#1195
US20230310689A1
Human necessities

UV LAMP COMPRISING AN AIR GUIDE FOR IMPROVING THE FUNCTION

#1196 ✅ Patent 11,857,707 granted on 2024-01-02
US20230310690A1
Human necessities

Germicidal partition for doorways and portals

#1197
US20230310691A1
Human necessities

FLUID DISPERSAL APPARATUS FOR AIR QUALITY CONTROL OF TRANSITORY SOURCE

#1198
US20230310692A1
Human necessities

ADVANCED DRESSING CONTAINING A POLYCAPROLACTONE POROUS MEMBRANE

#1199
US20230310693A1
Human necessities

Therapeutic And Cosmetic Wound Treatment

#1200 ✅ Patent 12,036,335 granted on 2024-07-16
US20230310694A1
Human necessities

Adhesive containing microparticles